The antibacterial medicine sales in Italy were forecasted to fall from 576.8 million USD in 2024 to 332.2 million USD by 2028. The trend indicates a consistent annual decrease in sales with a significant drop year-on-year: 10.7% from 2024 to 2025, 11.9% from 2025 to 2026, 13.4% from 2026 to 2027, and 15.3% from 2027 to 2028. Calculating the Compound Annual Growth Rate (CAGR), sales are anticipated to decrease at an average annual rate of approximately 12.6% over the next five years.
Future trends to watch for include the impact of antibiotic stewardship programs, changes in healthcare regulations, shifts toward alternative treatments, and potential resistance to antibiotics that might influence future market dynamics.
